Abstract:Imaging or therapeutic agents larger than the blood-brain barrier's (BBB) exclusion threshold of 400 Da could be delivered locally, non-invasively and reversibly by focused ultrasound (FUS) with circulating microbubbles. The size of agents is an important factor to the delivery outcome using this method. Liposomes are important drug carriers with controllable sizes in a range of nanometers. However, discrepancies among deliveries of intact liposomes with different sizes, especially those larger than 50 nm, across the BBB opened by FUS with microbubbles remain unexplored. In the present study, rhodamine-labeled long-circulating pegylated liposomes with diameters of 55 nm, 120 nm and 200 nm were delivered to mice brains after BBB disruption by pulsed FUS with microbubbles. Four groups of peak rarefactional pressure and microbubble dosages were used: 0.53 MPa with 0.1 mL/g (group 1), 0.53 MPa with 0.5 mL/g (group 2), 0.64 MPa with 0.1 mL/g (group 3) and 0.64 MPa with 0.5 mL/g (group 4). The delivery outcome was observed using fluorescence imaging of brain sections. It was found that the delivery of 55-nm liposomes showed higher success rates than 120-nm or 200-nm liposomes from groups 1-3. The result indicated that it may be more difficult to deliver larger liposomes (. 120 nm) passively than 55-nm liposomes after BBB opening by FUS with microbubbles. The relative fluorescence area of 55-nm liposomes to the total area of the sonicated region was statistically larger than that of the 120-nm or 200-nm liposomes. Increasing peak rarefactional pressure amplitude or microbubble dose could induce more accumulation of liposomes in the brain using FUS with microbubbles. Moreover, the distribution pattern of delivered liposomes was heterogeneous and characterized by separated fluorescence spots with cloud-like periphery surrounding a bright center, indicating confined diffusion in the extracellular matrix after extravasation from the microvasculature. These findings are expected to provide useful information for developing FUS with microbubbles as an effective trans-BBB liposomal drug delivery strategy. (C) 2016 World Federation for Ultrasound in Medicine & Biology.

Positioning release of the complex of ultrasound microbubbles and poly lactate glycollic acid nano microspheres in the liver of mice

Preparation and Antitumor Activity of Bfgf-Mediated Active Targeting Doxorubicin Microbubbles

PLGA nanoparticles introduction into mitoxantrone-loaded ultrasound-responsive liposomes: In vitro and in vivo investigations

Novel lactoferrin-conjugated amphiphilic poly(aminoethyl ethylene phosphate)/poly(L-lactide) copolymer nanobubbles for tumor-targeting ultrasonic imaging

Preparation and Ultrasonic Imaging Investigation of Perfluoropentane-Filled Polylactic Acid Nanobubbles As a Novel Targeted Ultrasound Contrast Agent

Development of Novel ST68/PLA-PEG Stabilized Ultrasound Nanobubbles for Potential Tumor Imaging and Theranostic

Preparation of Drug-loaded Nanobubbles and Their Ultrasound-mediated Antitumor Effect

Efficient ultrasound-mediated drug delivery to orthotopic liver tumors – Direct comparison of doxorubicin-loaded nanobubbles and microbubbles

Low Frequency Ultrasound Triggering Drug Release from Improved PLGA Microcapsules in Vitro

Preparation of Asialoglycoprotein Receptor-Mediated Hepatic Targeting Nano- Lipid Ultrasound Contrast Agent and Its Ultrasound Imaging in Vitro

Synthesis, characterization and in vitro and in vivo investigation of C₃F₈-filled poly(lactic-co-glycolic acid) nanoparticles as an ultrasound contrast agent.

Passive Targeting Study of Nanoscale Lipid Ultrasound Contrast Agents on Tumors

Superparamagnetic PLGA–iron oxide microspheres as contrast agents for dual-imaging and the enhancement of the effects of high-intensity focused ultrasound ablation on liver tissue

Development and optimization of doxorubicin loaded poly(lactic-co-glycolic acid) nanobubbles for drug delivery into HeLa cells.

Lactoferrin-Conjugated Polylactic Acid Nanobubbles Encapsulated Perfluoropentane as a Contrast Agent for Ultrasound/Magnetic Resonance Dual-Modality Imaging

Preparation and Imaging Investigation of Dual-targeted C3F8-filled PLGA Nanobubbles as a Novel Ultrasound Contrast Agent for Breast Cancer

Delivery of Liposomes with Different Sizes to Mice Brain after Sonication by Focused Ultrasound in the Presence of Microbubbles.

Gd-DTPA-loaded PLGA Microbubbles As Both Ultrasound Contrast Agent and MRI Contrast Agent--a Feasibility Research.

Reaserch on nanoscale liquid fluorocarbon poly lactic-co-glycolic acid ultrasound microcapsule for the cambination of ultrasound imaging and photothermal therapy

Enhanced Gene Delivery by Ultrasound and Contrast Agent: Experimental Study

Enhanced Ultrasound Imaging and Anti-Tumor in Vivo Properties of Span–polyethylene Glycol with Folic Acid–carbon Nanotube–paclitaxel Multifunctional Microbubbles